4//SEC Filing
Berrey M Michelle 4
Accession 0001104659-21-081624
CIK 0001270073other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:01 PM ET
Size
7.9 KB
Accession
0001104659-21-081624
Insider Transaction Report
Form 4
Berrey M Michelle
President, R&D and CMO
Transactions
- Award
Common Stock
2021-06-14+67,118→ 67,118 total - Award
Option to Purchase Common Stock
2021-06-14+93,000→ 93,000 totalExercise: $21.38Exp: 2031-06-14→ Common Stock (93,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the shares subject to the award will vest on the first anniversary of the Vesting Commencement Date, and the remaining shares will vest in equal quarterly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021.
- [F2]1/4th of the options subject to the award will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the remaining options will vest and become exercisable in equal monthly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001397329
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:01 PM ET
- Size
- 7.9 KB